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Ginseng has been used in China for at least two millennia and is now popular in over 35 countries. It is
one of the world’s popular herbs for complementary and alternative medicine and has been shown to
have helpful effects on cognition and blood circulation, as well as anti-aging, anti-cancer, and anti-
diabetic effects, among many others. The pharmacological activities of ginseng are dependent mainly on
ginsenosides. Ginsenosides have a cholesterol-like four trans-ring steroid skeleton with a variety of sugar
moieties. Nuclear receptors are one of the most important molecular targets of ginseng, and reports have
shown that members of the nuclear receptor superfamily are regulated by a variety of ginsenosides. Here,
we review the published literature on the effects of ginseng and its constituents on two main sex steroid
hormone receptors: estrogen and androgen receptors. Furthermore, we discuss applications for sex
steroid hormone receptor modulation and their therapeutic efﬁcacy.
Copyright  2016, The Korean Society of Ginseng, Published by Elsevier. This is an open access article
under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).1. Introduction
Ginseng has been used for over 2,000 y as a medicine in East
Asia. It is a popular herb in the world, and is used in more than 35
countries as a food, health supplement, and natural remedy [1].
Ginseng has been demonstrated to have an extensive range of
pharmacological effects on the reproductive, cardiovascular,
endocrine, and immune systems. Its ability to diminish fatigue,
enhance blood circulation, aid menopausal symptoms, boost im-
mune function, and enhance concentration has been veriﬁed in
certain countries [2]. Many components of ginseng, such as ginse-
nosides, polysaccharides, peptides, polyacetylenic alcohols, and
fatty acids, have been isolated and characterized [3,4]. However,
further research is necessary to understand how these components
contribute to ginseng’s pharmacological properties. Among these
constituents, dammarane-type ginsenosides, comprising a rigid
steroid skeleton consisting of four transrings with a modiﬁed side
chain at Ce20, have received considerable attention because of
their biological activity [5,6]. To date, more than 100 different
ginsenosides with various pharmacological effects have beenand Biotechnology, Sejong Univers
ht  2016, The Korean Society of G
d/4.0/).
l., Effects of ginseng on twom
x.doi.org/10.1016/j.jgr.2016.0isolated and identiﬁed from the root of Panax ginseng, with ginse-
nosides Rb1, Rb2, Rg1, and Re being most abundant. In addition,
steaming and drying during processing of ginseng can affect its
pharmacological activity by altering the characteristics of the
constituent ginsenosides [7e12]. Red ginseng, produced by
steaming fresh ginseng, possesses unique ginsenosides (Rg3, Rg5,
Rh2, Rh3, Rh4, Rs3, and F4) [13e15].
The molecular target of ginsenosides may be located either in
the cellular membrane or inside the cell, depending on the hy-
drophobicity of the ginsenoside [16]. Most ginsenosides are lipo-
philic in nature; with their steroidal backbone they can traverse cell
membranes by simple diffusion, and regulate cellular functions by
binding to speciﬁc intracellular target proteins in the cytoplasm
and nucleus [16]. The nongenomic pathway of ginsenoside activity
involves binding to membrane-associated receptors that initiate
the activation of the phosphorylation cascade and generation of
second messengers. Ginsenosides activate the genomic pathway by
initially binding to intracellular nuclear hormone receptors, such as
the glucocorticoid receptor, progesterone receptor, androgen re-
ceptor (AR), mineralocorticoid receptor, estrogen receptor (ER),ity, Kwang-Jin-Gu, Seoul 05006 South Korea.
inseng, Published by Elsevier. This is an open access article under the CC BY-NC-ND
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Fig. 1. Ginsenosides modulating estrogen receptor pathway. A summarized diagram of ginsenosides affecting the estrogen receptor pathway via genomic and nongenomic
pathways. COX-2, cyclooxygenase-2; eNOS, endothelial nitric oxide synthase; ER, estrogen receptor; iNOS, inducible nitric oxide synthase; PI3K, phosphatidylinositol-3 kinase; NO,
nitric oxide; MAPK, p38 mitogen-activated protein kinase; AMPK, AMP-activated protein kinase.
J Ginseng Res 2016;-:1e72peroxisome proliferator-activated receptor, and liver X receptor
[17e29]. Many studies have shown that ginsenosides act through
nuclear hormone receptors. For example, one study found that
administration of ginseng extract for about 1.5 wk inhibited the
activity of peroxisome proliferator-activated receptor-a and the
expression of several genes associated with lipid and lipoprotein
metabolism [30]; presumably, ginsenosides were the active con-
stituents. Ginsenosides enhanced the expression levels of gluco-
corticoid receptor in the brain cytosol of heat-injured rats [31]. In
another study, the interaction of ginsenoside-activated glucocorti-
coid receptors triggered the activation of the phosphatidylinositol-
3 kinase (PI3K)/Akt pathway and increased nitric oxide production
in human umbilical vein endothelial cells [32]. Ginsenosides act
through not only steroid hormone receptors, but also ion channels.
One study showed that ginsenosides inhibit voltage-dependent
calcium, potassium, and sodium channel activities in a stereospe-
ciﬁc manner, and block subtypes of nicotinic acetylcholine and 5-
hydroxytryptamine type 3 receptors [33].
Here, we review the ginsenosides that affect estrogen and
androgen activities, including those that directly or indirectly
modulate ERs and ARs. We also discuss clinical studies of ginseng
on female and male reproductive functions.
2. Effects on ERa and ERb
2.1. Genomic and nongenomic action
Estrogens are female steroid hormones that are produced
mainly by the ovaries through the conversion of cholesterol. Es-
trogens can also be produced locally in the placenta, adrenal glands,
adipose tissue, and brain, where they act in a paracrine fashion [34].
Estrogens are essential in the development and maintenance of the
female reproductive system, immune system, cardiovascular sys-
tem, and central and peripheral nervous systems; they also regulate
bone metabolism [35]. As a consequence of their wide range of
physiological roles, estrogens are also involved in manyPlease cite this article in press as: Park J, et al., Effects of ginseng on twom
Journal of Ginseng Research (2016), http://dx.doi.org/10.1016/j.jgr.2016.0pathological states, including cancer, metabolic and cardiovascular
diseases, neurodegeneration, and osteoporosis [36].
Phytoestrogens are compounds of plant origin that can exert
estrogenic properties, through either directly binding to ER or
indirectly activating ERs [36e38]. Phytoestrogens, such as genistein
and daidzein, have shown protective effects on conditions related
to decreased estrogen, including menopause, osteoporosis, and
cognitive disorders [39,40]. The interest in the use of phytoes-
trogens stems from epidemiologic studies suggesting a decreased
incidence of breast cancer, and lower occurrence and complaints of
menopausal symptoms and osteoporosis in women from countries
with high consumption of phytoestrogens, mainly found in soy
products [41e44].
Cellular effects of estrogens are mediated by ERs, which are
transcription factors activated by ligands. Two distinct isoforms
exist: ERa and ERb. The expression patterns of these two receptors
differ and display distinct characteristics. ERa is expressed mainly
in reproductive tissues such as the uterus and ovary, breast, bone,
white adipose tissue, and liver. ERb is expressed mainly in the
ovary, central nervous system, cardiovascular system, lung, pros-
tate, colon, and the immune system [36,45,46].
The classical estrogen action model suggests that nuclear ER
changes its conformation upon ligand binding, binds to the cognate
estrogen-responsive element, and modulates the transcription of
target genes [47,48]. Hundreds of coactivator/corepressor regula-
tory proteins affect the ER-mediated transcriptional response. ERs
are mainly found in the nucleus and also in the cytoplasmic
membrane. Estrogen binds to the membrane receptors and stim-
ulates signaling proteins. The nongenomic pathway triggers G
protein-coupled receptors, generates calcium ﬂux, stimulates cyclic
adenosine monophosphate (cAMP) and cyclic guanosine mono-
phosphate (cGMP) production, and activates the PI3K and extra-
cellular-signal-regulated kinase (ERK) pathways [49e51]. Recent
researches indicate that ERs were also identiﬁed in mitochondria
and endosomes, and that the act of signaling from all these sites
must be integrated with nuclear ER action to produce the ﬁnalain sex steroid hormone receptors: estrogen and androgen receptors,
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Table 1
Ginsenosides modulating estrogen receptor pathway
Ginsenosides/total ginseng Experimental model systems Observations Signaling molecules monitored Reference no.
Total ginseng
Korean Red Ginseng SK-N-SH human neuroblastoma cells, mate ICR
mice model
Inhibits oxidative stress and apoptosis PADI4, p53, Bcl-2 COX-2, ERb [24]
SK-N-SH human neuroblastoma cells Antioxidant and represses apoptosis PI3K/Akt, Bcl-2, p53, Caspase-3 [61]
Radix Ginseng Immature Kunming mice Estrogen effect on reproductive tissues ERa, ERb [25]
P. ginseng Ovariectomized mice Can treat postmenopausal symptoms through action as an
estrogen agonist
ERa, ERb [26]
MCF-7 human breast cancer cells Estrogenic activity in vitro but not in vivo ERa [27]
Ginsenosides
Rb1 MCF-7 human breast cancer cells, COS monkey
kidney cells
Estrogen-like activity [63]
Human umbilical vein endothelial cells Inhibits capillary morphogenesis [71]
Ovariectomized mice Estrogen-like effect on brain 5-HT levels [72]
PC12 rat pheochromocytoma cells Prevents MPPþ-induced apoptosis ERK1/2, SAPK/JNK, p38 MAPK [73]
Human articular chondrocytes Anti-inﬂammatory and apoptotic properties IL-1b, PGE2, COX-2, iNOS, Caspase-3, NO2e, MMP-3 [74]
Rg1 MCF-7 human breast cancer cells Proliferation IGF-IR [75]
MCF-7 human breast cancer cells Estrogen-like activity MAPK [76]
Ovariectomized rat model of Alzheimer’s
disease
Neuroprotective effect Caspase-3 [77]
Primary rat cerebrocortical neurons Neuroprotective effect ERK1/2 [19]
HT-22 hippocampal neuronal cells, SH-SY5Y
human neuroblastoma cells, Ovariectomized
rats
Promotes nonamyloidgenic cleavage of beta-amyloid
precursor protein
PI3K/Akt, MAPK [78]
N2a-APP694 mouse neuronal cells Prevents memory loss PPARg [28]
SK-N-SH human neuroblastoma cells Apoptosis IGF-IR [79]
Bone marrow stromal cells Proliferation, activates ER-mediated signaling [80]
MCF-7, MDAMB human breast cancer cells Estrogen-like activity [81]
Rg3 PC-3M prostate cancer cells Inhibits migration AQP1, p38 MAPK [29]
ECV304 human endothelial cells Endothelial NO production PI3K/Akt, AMPK, JNK, p38 [82]
Re Embryonic rat thoracic aortic smooth muscle
cells from DBIX rat (A10 cells)
1. Releases NO via membrane sex steroid receptors
2. Promotes vasodilation
3. Activates potassium channels
PI3K/Akt [83]
Single ventricular myocytes, MCF-7 human
breast cancer cells, LNCaP human prostate
cancer cells
Activates cardiac potassium channels via nongenomic
pathway of sex hormone
[84]
Notoginsenoside Ft1 Rat mesenteric arteries model NO-mediated relaxation PI3K/Akt, ERK1/2 [20]
Notoginsenoside R1 Endotoxemic mice Anti-inﬂammation, protects the heart from septic shock NF-kB, I-kB, PI3K/Akt [85]
Rat primary osteoblastic cells Stimulates osteoblast differentiation via ER signaling [86]
P. ginseng ginsenoside Rh1 MCF-7 human breast cancer cells Weak phytoestrogen [87]
Ginsenoside metabolites
Protopanaxadiol Primary human umbilical vein endothelial cells Functional ligands for both GR and ERb [88]
Protopanaxatriol Primary human umbilical vein endothelial cells Functional ligands for both GR and ERb [88]
AR
P. ginseng LNCaP human prostate cancer cells Inhibit AR signaling by stimulating the degradation of AR
protein
Antiproliferation, apoptosis
AR [21]
C57BL/6 mice model, human hair follicle papilla
cells
Antiandrogen, promotes hair growth in humans ERK, Akt [23]
20(s)-25-Methoxyl-
dammarane-3beta, 12beta,
20-triol (20-OCH3-PPD)
e In vitro:
Human LNCaP (P53 wild type, androgen
dependent), PC3 (P53 null, androgen
independent), IMR90-EEA and IMR90-E1A
human primary ﬁbroblast cell lines
e In vivo:
Prostate cancer (PC3) xenograft model
Inhibits the expression of androgen receptors,
antiproliferation, apoptosis
PARP, Bax, Bcl-2, cyclin D [22]
AR, androgen receptor; COX-2, cyclooxygenase-2; ER, estrogen receptor; GR, glucocorticoid receptor; IL, interleukin; iNOS, inducible nitric oxide synthase; MMP-3, matrix metalloproteinase-3; NF-kB, nuclear factor-kB; NO,
nitric oxide; PI3K, phosphatidylinositol-3 kinase; PPAR, peroxisome proliferator-activated receptor; 5-HT, 5-hydroxytryptamine
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J Ginseng Res 2016;-:1e74functions of the steroid [52,53]. Studies using a xenograft model of
MCF-7 human breast cancer cells injected into nude mice have
shown that engagement of only the membrane receptor by an es-
trogenic compound failed to stimulate tumor proliferation [54].
This indicates that nongenomic and genomic pathways of ER
communicate, which is likely to play a role in promoting human
breast tumor growth. Cellular effects of ginsenosides can be inﬂu-
enced by many factors, including concentration, receptor status,
amount of endogenous estrogens, and target tissue [55]. Some
phytoestrogens display different afﬁnities to ER isoforms [56]. No
study has shown antiestrogenic effects of ginsenosides, but both
estrogenic and antiestrogenic activities have been reported for
genistein [57,58].
Treatment with P. ginseng upregulated both ERa and ERb in the
reproductive organs (e.g., uterus and vagina) of both normal and
ovariectomized mice, demonstrating that P. ginseng had a potent
estrogenic activity [25,26]. However, P. ginseng upregulated the
expression of ERa to a greater extent than that of ERb in the uterus
and vagina, suggesting that P. ginseng selectively binds to ERa in
these reproductive tissues [25,26]. However, ERb antagonizes ERa-
mediated effects in reproductive tissues, such as the breast, ovary,
prostate, and uterus [59,60]. In contrast to the effects seen in
reproductive organs, treatment of immobilized mice brains and
in vitro treatment of neuroblastoma SK-N-SH cells with hydrogen
peroxide depressed ERb, but not ERa [24]. Korean Red Ginseng
(KRG) upregulates ERb and subsequently mitigates stress-induced
gene expression [24]. Consistently, in vitro studies also demon-
strated that KRG represses apoptosis by potentiating PI3K/Akt
signaling via ERb upregulation [61,62]. For instance, KRG appears to
repress stress-induced tumor necrosis factor-a converting enzyme
and nuclear factor-kB in immobilized mice brains and H2O2-
induced neuroblastoma SK-N-SH cells, thus preventing the pro-
duction of reactive oxygen species and protecting brain cells from
apoptosis [24,61,62]. Thus, in the brain, ERb seems to inhibit
apoptosis and antagonize oxidative stress.
Regarding the mechanisms of action of KRG components, the
major ginsenoside Rb1 dose dependently activated both ERa and
ERb in COS monkey kidney cells, but it did not bind to the ER re-
ceptors in MCF-7 breast cancer cells [63]. In contrast, the anti-
angiogenic effects of the ginsenoside Rb1 have been ascribed to its
interaction with ERb in vitro. Rb1 speciﬁcally increased the
expression of a potent antiangiogenic protein pigment epithelium-
derived factor by binding to ERb, but not to ERa, resulting in the
inhibition of endothelial tube formation [64]. These results suggest
that KRGmight affect ERb expression in a tissue- and organ-speciﬁc
manner.
Reproduction is controlled mainly by estradiol in an ERa-
dependent manner. Furthermore, brain functions are profoundly
mediated by ERa, but not by ERb [65,66], and most research on ERb
has focused on brain function and behavior [67]. However, in the
brain, ERa and ERb are usually tightly controlled in an interrelated
and estradiol-dependent manner for a particular brain function
[67]. ERb modulation is also common; for example, hypernatremia
stress and immobilization stress downregulate ERb expression
[24,68]. In contrast, P. ginsengmay upregulate ERb in the brain, and
ERb may counteract stress via antiapoptotic and antioxidative ac-
tivities [24]. Although the underlying mechanism for this effect
requires further study, one possible explanation is that KRG upre-
gulates the steroidogenic enzyme P450 (Cyp11a1) [69]. Cyp11a1
catalyzes the initial and rate-limiting step in steroid hormone
synthesis, and cleaves the cholesterol side chain into pregnenolone
with a steroidogenic potential [70]. However, an interaction be-
tween ERa and ERb cannot be ruled out; further research on the
interaction between these two proteins in the brain is therefore
required to clarify the underlying mechanism.Please cite this article in press as: Park J, et al., Effects of ginseng on twom
Journal of Ginseng Research (2016), http://dx.doi.org/10.1016/j.jgr.2016.0Fig. 1 and Table 1 summarizes the modulating effects of ginse-
nosides upon the ER pathway.
2.2. Clinical studies on menopausal symptoms, erectile dysfunction,
and women’s sexual function
Ginseng has often been used for management of menopausal
symptoms in postmenopausal women, and sexual function in both
men and women. One systematic review suggested that the evi-
dence on efﬁcacy of ginseng for managing menopausal symptoms
was limited [89]. Three randomized controlled trials (RCTs), which
were included in the review, tested the efﬁcacy of KRG compared
with placebo, and their results showed superior effects of KRG on
sexual arousal and global health [90e92]. Another trial reported
favorable effects of ginseng supplements on well-being and
depression as compared with placebo [93].
Regarding the efﬁcacy of KRG for sexual function in men, one
systematic review investigated the efﬁcacy of KRG for erectile
dysfunction (ED) compared with placebo [94]. This review included
seven RCTs, and their results suggested superior effects of KRG on
improvement of ED compared with placebo. Recently, two addi-
tional RCTs also reported positive effects of KRG on ED [95,96].
Collectively, the evidence on the efﬁcacy of KRG for treating ED is
highly signiﬁcant.
For the effects of KRG on women’s sexual function, three
crossover RCTs tested the efﬁcacy of KRG for the sexual function of
women comparedwith placebo control [90,97,98]. One RCT showed
positive effects of KRG on sexual arousal [90], and the other two
RCTs reported improvement of sexual function without statistical
signiﬁcance compared with placebo control [97,98].
3. Effects on AR
Androgens mediate a wide range of male developmental pro-
cesses, and are especially important in male sexual differentiation
as well as pubertal maturation, maintenance of spermatogenesis,
and male gonadotropin regulation [99]. Testosterone and its
metabolite 5-a-dihydrotestosterone, two principal androgens,
exert their function predominately through AR-mediated pathways
[100]. Disorganization of the androgeneAR complex results in
androgen insensitivity syndrome, eventually leading to dysfunc-
tions of the male reproductive system, such as subfecundity or
infertility. Defects in the AR lead to distinct signs of under-
virilization and undermasculinization in males [101]. Disturbance
of the androgeneAR complex is triggered mainly by mutations in
the AR gene. Mutations in the AR gene are inherited in an X-linked
recessive pattern and, therefore, affect malesmuchmore frequently
than females [102].
Melo et al [103] studied the relationship between male infer-
tility and androgen AR mutations in Brazilian patients, and postu-
lated that patients who do not produce sperm have a higher
number of AR mutations than those with merely impaired sperm
production.
While the expression level of AR itself, as well as luteinizing
hormone receptor (LHR) and follicle-stimulating hormone receptor
(FSHR), may also contribute to androgen insensitivity and male
sub- and/or infertility, this idea has not received much scientiﬁc
attention to date. This topic has largely been overlooked in the
biochemical and pharmacological communities, as well as in urol-
ogy. The expression levels of proteins and mRNAs for AR, LHR, and
FSHR in testicular tissue from aged and doxorubicin-sensitized
Sprague-Dawley rats, were signiﬁcantly downregulated in these
animals as well as in animals stress loaded by intermittent immo-
bilization (2 h/d for 8 wk/6 mo) and heat (32C, 2 h/d for 8 wk/6
mo). Pretreatment with KRG markedly prevented theain sex steroid hormone receptors: estrogen and androgen receptors,
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the Center for Disease Prevention and Control in Shenyang Com-
mand, Shenyang, China, carried out a similar experiment in cold-
stressed rats. They reported that ginseng polysaccharides upregu-
lated ARmRNA expression levels and promoted testosterone. These
results indicate that P. ginseng plays an important role in main-
taining healthy levels of steroid hormone receptors, including AR,
which in turn ensures the proper functioning of androgens.
4. Conclusion
Ginseng has been used for various pathological problems, as
well as for preventing and enhancing overall physiological func-
tions. The effects of ginsengs in cancer chemoprevention and
therapeutics are one of the most intensively studied areas. Identi-
ﬁcation of cellular targets responsible for such activity and char-
acterization of active red ginseng compounds still requires
continuous research. Nuclear hormone receptors are one of the
cellular targets of ginsenosides that are lipophilic in nature. ER is
one of the well-studied targets for ginsenosides among the mem-
bers of nuclear steroid hormone receptors. Modulation of ERs by
ginseng components can be beneﬁcial to estrogen-dependent
cancer and many physiological states deriving from low levels of
estrogen hormones due to aging as well as inevitable ovary-related
surgery in younger women. As shown, studies targeting ARs and
androgen-associated physiological states are less studied. Even
with accumulating data on estrogen-mimicking or supplemental
activity of ginseng in humans, additional accumulative data are still
required to establish and provide a scientiﬁc basis of ginseng use on
sex steroid hormone-dependent function.
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